<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Yang L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Ventricular-like human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exhibit the electrophysiological characteristics of spontaneous beating. Previous studies demonstrated that dexmedetomidine (DMED), a highly selective and widely used α&lt;sub>2&lt;/sub>-adrenoceptor agonist for sedation, analgesia, and stress management, may induce antiarrhythmic effects, especially ventricular tachycardia. However, the underlying mechanisms of the DMED-mediated antiarrhythmic effects remain to be fully elucidated.&lt;h4>Methods&lt;/h4>A conventional patch-clamp recording method was used to investigate the direct effects of DMED on spontaneous action potentials, pacemaker currents (&lt;i>I&lt;/i> &lt;sub>f&lt;/sub>), potassium (K&lt;sup>+&lt;/sup>) channel currents (&lt;i>I&lt;/i> &lt;sub>K1&lt;/sub> and &lt;i></pubmed_abstract><journal>Annals of translational medicine</journal><pagination>399</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8033317</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism.</pubmed_title><pmcid>PMC8033317</pmcid><pubmed_authors>Zheng J</pubmed_authors><pubmed_authors>Witman N</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Tan Y</pubmed_authors><pubmed_authors>Fu W</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Gong Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism.</name><description>&lt;h4>Background&lt;/h4>Ventricular-like human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exhibit the electrophysiological characteristics of spontaneous beating. Previous studies demonstrated that dexmedetomidine (DMED), a highly selective and widely used α&lt;sub>2&lt;/sub>-adrenoceptor agonist for sedation, analgesia, and stress management, may induce antiarrhythmic effects, especially ventricular tachycardia. However, the underlying mechanisms of the DMED-mediated antiarrhythmic effects remain to be fully elucidated.&lt;h4>Methods&lt;/h4>A conventional patch-clamp recording method was used to investigate the direct effects of DMED on spontaneous action potentials, pacemaker currents (&lt;i>I&lt;/i> &lt;sub>f&lt;/sub>), potassium (K&lt;sup>+&lt;/sup>) channel currents (&lt;i>I&lt;/i> &lt;sub>K1&lt;/sub> and &lt;i></description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T21:24:34.013Z</modification><creation>2025-04-04T21:24:34.013Z</creation></dates><accession>S-EPMC8033317</accession><cross_references><pubmed>33842620</pubmed><doi>10.21037/atm-20-5898</doi></cross_references></HashMap>